ARTICLE | Distillery Therapeutics
Cancer
April 25, 2017 3:59 PM UTC
Patient sample and cell culture studies suggest promoting KCNQ1 expression or inhibiting its negative regulator TCF4 could help treat colorectal cancer. In patients, low levels of KCNQ1 and high level...
BCIQ Company Profiles